4-Bromomethyl-pyridine

Names

[ Name ]:
4-Bromomethyl-pyridine

[Synonym ]:
4-Bromomethyl-pyridine
4-(bromomethyl)pyridine,hydrobromide
Pyridine, 4-(bromomethyl)-, bromide, hydrogen salt (1:1)
MFCD01863545
Hydrogen bromide 4-(bromomethyl)pyridine (1:1:1)

Chemical & Physical Properties

[ Melting Point ]:
189-192ºC

[ Molecular Formula ]:
C₆H₇Br₂N

[ Molecular Weight ]:
252.934

[ Exact Mass ]:
250.894516

[ PSA ]:
12.89000

[ LogP ]:
2.93460

MSDS

Safety Information

[ Symbol ]:

GHS05

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H314

[ Precautionary Statements ]:
P280-P305 + P351 + P338-P310

[ Personal Protective Equipment ]:
Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges

[ Hazard Codes ]:
C:Corrosive;

[ Risk Phrases ]:
R34

[ Safety Phrases ]:
S26-S36/37/39-S45

[ RIDADR ]:
UN 3261

[ WGK Germany ]:
3

[ Packaging Group ]:
Ⅱ

[ HS Code ]:
2933399090

Synthetic Route

Click to get detail synthetic route

Customs

[ HS Code ]: 2933399090

[ Summary ]:
2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles

Nucleolipid nanovectors as molecular carriers for potential applications in drug delivery.

Mol. Biosyst. 7(11) , 3075-86, (2011)

Novel thymidine- or uridine-based nucleolipids, containing one hydrophilic oligo(ethylene glycol) chain and one or two oleic acid residues (called ToThy, HoThy and DoHu), have been synthesized with th...

Synthesis, structural elucidation and DNA-dependant protein kinase and antiplatelet studies of 2-amino-[5, 6, 7, 8-mono and 7, 8-di-substituted]-1,3-benzoxazines.

Eur. J. Med. Chem. 45(11) , 4934-46, (2010)

A number of new 2-amino-[5, 6, 7 and 8]-O-substituted 1,3-benzoxazines, and 2-amino 8-methyl-7-O-substituted-1,3-benzoxazines were synthesized. Thirty one new compounds were tested for their effect on...

Preparation and antileishmanial activity of lipophilicN-alkyl diamines

Biomed. Pharmacother. 63(1) , 40-2, (2009)

We report in this work the preparation and the in vitro antileishmanial activity of a series of long chains N-monoalkylated diamines and two pyridinediamine derivatives. Several compounds, tested for ...

methyl 4-bromomethyl-pyridine-2-carboxylate
4-(bromomethyl)pyridine,hydrochloride
ethyl 4-(bromomethyl)pyridine-3-carboxylate
ethyl 4-(bromomethyl)pyridine-2-carboxylate
methyl 4-(bromomethyl)pyridine-3-carboxylate
2-bromo-4-(bromomethyl)pyridine,hydrochloride
Methyl 1-[[(E)-4-(dimethylamino)but-2-enoyl]amino]-4-methyl-3,4-dihydro-2H-naphthalene-1-carboxylate
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
(4-Methyl-tetrahydro-furan-2-yl)-methanol
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
tert-Butyl-DL-alanine
4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide